Publication:
Advanced Glycation End Products and Their Involvement in Cardiovascular Disease.

Simple item page
dc.contributor.authorYubero-Serrano, Elena M
dc.contributor.authorPerez-Martinez, Pablo
dc.contributor.funderConsejería de Salud
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2023-02-08T14:44:38Z
dc.date.available2023-02-08T14:44:38Z
dc.date.issued2020-04-03
dc.description.abstractCirculating levels and tissue accumulation of advanced glyca-tion end products (AGEs) are strongly linked with metabolicimbalance and the progression of chronic diseases, includingcardiovascular disease (CVD). 1,2 Diet is the most importantexogenous source of AGEs contributing to the total body AGEsload. Experimental and clinical evidence suggests that thereduction in body AGE content, by dietary AGE restriction,could modulate different pathways involved in the pathophy-siology of CVD
dc.identifier.citationYubero-Serrano EM, Pérez-Martínez P. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Angiology. 2020 Sep;71(8):698-700
dc.identifier.doi10.1177/0003319720916301
dc.identifier.essn1940-1574
dc.identifier.pmid32242451
dc.identifier.urihttp://hdl.handle.net/10668/15315
dc.issue.number8
dc.journal.titleAngiology
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number698-700
dc.publisherSage Publications
dc.pubmedtypeEditorial
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDPC-0283/2017
dc.relation.projectIDPI18/01822
dc.subjectAdvanced glycation end products
dc.subjectCardiovascular diseases
dc.subjectDiet
dc.subject.decsConducta de reducción del riesgo
dc.subject.decsDieta mediterránea
dc.subject.decsEnfermedades cardiovasculares
dc.subject.decsMedición de riesgo
dc.subject.decsProductos finales de glicación avanzada
dc.subject.decsReceptor para productos finales de glicación avanzada
dc.subject.decsTransducción de señal
dc.subject.meshCardiovascular diseases
dc.subject.meshDiet
dc.subject.meshDiet, healthy
dc.subject.meshDiet, mediterranean
dc.subject.meshGlycation end products, advanced
dc.subject.meshHumans
dc.subject.meshProtective factors
dc.subject.meshReceptor for advanced glycation end products
dc.subject.meshRisk assessment
dc.subject.meshRisk factors
dc.subject.meshRisk reduction behavior
dc.subject.meshSignal transduction
dc.titleAdvanced Glycation End Products and Their Involvement in Cardiovascular Disease.
dc.typeresearch article
dc.volume.number71
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format
Download

Collections

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía